Scottish-based BioOutsource Ltd Opens First US Facility At Cambridge Massachusetts Innovation Center
04/24/2013
“We have opened this new office, our first in the U.S., in response to increasing demand from across the North American market for our market-leading BioAnalytical services, and particularly in the field of biological biosimilar characterization,” BioOutsource CEO Gerry MacKay said. “Our U.S. office will facilitate engagement with North American customers for our off-the-shelf biosimilar biological characterization assays, for example for Humira, Enbrel, Rituxan, Herceptin, Remicade, and Avastin.”
“We are in the fortunate position to have been first-to-market in both Europe and the U.S. with our assays, and count Big Pharma as well as leading biotechnology as valued customers,” said Verna McErlane, PhD, BioOutsource Director of Sales & Business Development, BioAnalytical Division. “We look forward to being able to interact with them and provide our market-leading services, that much more readily, from our North American base of operations in Cambridge. Cambridge is, of course, part of greater Boston, which is now the number one cluster for early-stage biotechnology, and a growing center of operations for some of the world’s leading pharmaceutical firms, as well.”
“We see the North American market as an essential strategic element of our global expansion plans. We remain committed to not only growing our business in North America but in nurturing our relationships with our existing North American clients, as well. We invite all our customers and potential customers to stop by our new offices whenever you are in the Boston area,” MacKay added.
Project Announcements
Kestra Holdings Plans Tempe, Arizona, Headquarters Operations
10/22/2025
Hainesport Transportation Group Plans Gallatin, Tennessee, Operations
10/21/2025
Japan-Based Meiden America Switchgear Expands Gray Court, South Carolina, Production Operations
10/21/2025
Swiss-Based Ypsomed Plans Holly Springs, North Carolina, Manufacturing Operations
10/20/2025
AstraZeneca Plans Albemarle County, Virginia, Production Operations
10/20/2025
Circular Composite Solutions Plans Bamberg, South Carolina, Operations
10/20/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025